Embryonic Stem Cells to Tackle Major Killer Diseases

October 2, 2014

(New Scientist) – In the most rigorous test of embryonic stems cells’ potential yet, six people with heart failure will be treated in France with a patch of immature heart cells made from hESCs, and 40 people with diabetes in the US will receive pouches containing immature pancreatic cells made from hESCs. The hope is that the heart patch will help to regenerate heart muscle destroyed by heart attacks. Trials in monkeys showed that the patch could regenerate up to 20 per cent of the lost muscle within two months.